Sharecare, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net (net of allowance for doubtful accounts of $8,091 and $8,544, respectively)
Other receivables
Prepaid expenses
Other current assets
Total current assets
Cash and investments held in Trust Account

Property and equipment, net
Other long-term assets
Intangible assets, net
Goodwill
Total assets
Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses
Accounts payable
Accrued expenses and other current liabilities (Note 3)
Deferred revenue
Contract liabilities, current
Debt, current (Note 7 and 13)
Debt, current
Total current liabilities

Deferred underwriting compensation
Warrant liabilities
Deferred underwriting compensation
Contract liabilities, noncurrent
Warrant liabilities
Long-term debt
Other long-term liabilities
Total liabilities
Class A common stock subject to possible redemption; 29,573,195 and 28,851,640 shares at redemption value of $10.00 per share at June 30, 2021 and December 31, 2020, respectively
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Redeemable noncontrolling interest
Series A redeemable convertible preferred stock, $0.0001 par value; 5,000,000 shares authorized; 5,000,000 shares issued and outstanding, aggregate liquidation preference of $50,000 as of June 30, 2024 and December 31, 2023
Common stock, shares authorized
Class A Common Stock
Class B Common Stock
Total common stock, shares authorized

Stockholders’ equity:
Common stock $0.0001 par value; 600,000,000 and 600,000,000 shares authorized; 367,662,956 and 353,430,357 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively
Class A Common Stock
Class B Common Stock
Total common stock $0.0001 par value; 600,000,000 and 600,000,000 shares authorized; 367,662,956 and 353,430,357 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively

Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Sharecare, Inc. stockholders’ equity
Class A Common Stock
Class B Common Stock
Total Sharecare, Inc. stockholders’ equity

Noncontrolling interest in subsidiaries
Total stockholders’ equity

Total liabilities, redeemable convertible preferred stock and stockholders’ equity

Comments